[1] |
Baechli H, Nordmann A, Bucher HC, et al. Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort study[J]. Neurosurg Rev, 2004, 27(4): 263-266.
|
[2] |
Ducruet AF, Grobelny BT, Zacharia BE, et al. The surgical management of chronic subdural hematoma[J]. Neurosurg Rev, 2012, 35(2): 155-169; discussion 169.
|
[3] |
Yadav YR, Parihar V, Namdev H, et al. Chronic subdural hematoma[J]. Asian J Neurosurg, 2016, 11(4): 330-342.
|
[4] |
Hernández-Díaz ZM, Llíbre-Guerra JC, Arteche-Prior M, et al. Spontaneous subdural hematoma and behavioral changes due to a dural arteriovenous fistula. A Case Report and Literature Review[J]. Behav Sci (Basel), 2019, 9(6): 63.
|
[5] |
Li G, Zhang Y, Zhao J, et al. Isolated subdural hematoma secondary to dural arteriovenous fistula: a case report and literature review[J]. BMC Neurol, 2019, 19(1): 43.
|
[6] |
Ban SP, Hwang G, Byoun HS, et al. Middle meningeal artery embolization for chronic subdural hematoma[J]. Radiology, 2018, 286(3): 992-999.
|
[7] |
中华医学会神经外科学分会,中国神经外科重症管理协作组.抗栓药物治疗中颅内出血患者神经外科围手术期管理中国专家共识(2018版)[J].中华医学杂志, 2018, 98(21): 1640-1645.
|
[8] |
Taussky P, Fandino J, Landolt H. Number of burr holes as independent predictor of postoperative recurrence in chronic subdural haematoma[J]. Br J Neurosurg, 2008, 22(2): 279-282.
|
[9] |
Han HJ, Park CW, Kim EY, et al. One vs. two burr hole craniostomy in surgical treatment of chronic subdural hematoma[J]. J Korean Neurosurg Soc, 2009, 46(2): 87-92.
|
[10] |
Kansal R, Nadkarni T, Goel A. Single versus double burr hole drainage of chronic subdural hematomas. A study of 267 cases[J]. J Clin Neurosci, 2010, 17(4): 428-429.
|
[11] |
Wan Y, Xie D, Xue Z, et al. Single versus double burr hole craniostomy in surgical treatment of chronic subdural hematoma: a meta-analysis[J]. World Neurosurg, 2019, 131: e149-e154.
|
[12] |
Oh HJ, Lee KS, Shim JJ, et al. Postoperative course and recurrence of chronic subdural hematoma[J]. J Korean Neurosurg Soc, 2010, 48(6): 518-523.
|
[13] |
Bartley A, Jakola AS, Tisell M. The influence of irrigation fluid temperature on recurrence in the evacuation of chronic subdural hematoma[J]. Acta Neurochir (Wien), 2020, 162(3): 485-488.
|
[14] |
Kuwabara M, Sadatomo T, Yuki K, et al. The effect of irrigation solutions on recurrence of chronic subdural hematoma: a consecutive cohort study of 234 patients[J]. Neurol Med Chir (Tokyo), 2017, 57(5): 210-216.
|
[15] |
Gernsback J, Kolcun JP, Jagid J. To drain or two drains: recurrences in chronic subdural hematomas[J]. World Neurosurg, 2016, 95: 447-450.
|
[16] |
Javadi A, Amirjamshidi A, Aran S, et al. A randomized controlled trial comparing the outcome of burr-hole irrigation with and without drainage in the treatment of chronic subdural hematoma: a preliminary report[J]. World Neurosurg, 2011, 75(5-6): 731-736; discussion 620-623.
|
[17] |
Alcalá-Cerra G, Young AM, Moscote-Salazar LR, et al. Efficacy and safety of subdural drains after burr-hole evacuation of chronic subdural hematomas: systematic review and meta-analysis of randomized controlled trials[J]. World Neurosurg, 2014, 82(6): 1148-1157.
|
[18] |
Yeo CG, Jeon WY, Kim SH, et al. The effectiveness of subdural drains using urokinase after burr hole evacuation of subacute subdural hematoma in elderly patients: a prelimilary report[J]. Korean J Neurotrauma, 2016, 12(2): 101-106.
|
[19] |
Cho SW, Choi SW, Lim J, et al. Burr hole drainage with urokinase irrigation for the treatment of acute subdural hematoma: a case report[J]. Korean J Neurotrauma, 2018, 14(2): 142-145.
|
[20] |
Lam J, Lee DJ, Oladunjoye A. Subdural catheter injection of tissue plasminogen activator for residual hematoma post drainage of acute-on-chronic subdural hematoma: novel case report of 2 patients[J]. World Neurosurg, 2020, 133: 266-270.
|
[21] |
Li Y, Yang R, Li Z, et al. Urokinase vs tissue-type plasminogen activator for thrombolytic evacuation of spontaneous intracerebral hemorrhage in basal ganglia[J]. Front Neurol, 2017, 8: 371.
|
[22] |
Iorio-Morin C, Blanchard J, Richer M, et al. Tranexamic acid in chronic subdural hematomas (TRACS): study protocol for a randomized controlled trial[J]. Trials, 2016, 17(1): 235.
|
[23] |
Schaumann A, Klene W, Rosenstengel C, et al. COXIBRAIN: results of the prospective, randomised, phase II/III study for the selective COX-2 inhibition in chronic subdural haematoma patients[J]. Acta Neurochir (Wien), 2016, 158(11): 2039-2044.
|
[24] |
Jiang R, Zhao S, Wang R, et al. Safety and efficacy of atorvastatin for chronic subdural hematoma in Chinese patients: a randomized clinical trial[J]. JAMA Neurol, 2018, 75(11): 1338-1346.
|
[25] |
Prud'homme M, Mathieu F, Marcotte N, et al. A pilot placebo controlled randomized trial of dexamethasone for chronic subdural hematoma[J]. Can J Neurol Sci, 2016, 43(2): 284-290.
|
[26] |
Yao Z, Hu X, Ma L, et al. Dexamethasone for chronic subdural haematoma: a systematic review and meta-analysis[J]. Acta Neurochir (Wien), 2017, 159(11): 2037-2044.
|
[27] |
Xu XP, Liu C, Liu J, et al. Local application of corticosteroids combined with surgery for the treatment of chronic subdural hematoma[J]. Turk Neurosurg, 2015, 25(2): 252-255.
|
[28] |
Tanweer O, Frisoli FA, Bravate C, et al. Tranexamic acid for treatment of residual subdural hematoma after bedside twist-drill evacuation[J]. World Neurosurg, 2016, 91: 29-33.
|
[29] |
林晓宁,田新华,孙瑾,等.慢性硬膜下血肿术后复发的危险因素分析[J].中华神经外科杂志, 2019, 35(3): 302-304.
|
[30] |
Kim SU, Lee DH, Kim YI, et al. Predictive factors for recurrence after burr-hole craniostomy of chronic subdural hematoma[J]. J Korean Neurosurg Soc, 2017, 60(6): 701-709.
|
[31] |
Motiei-Langroudi R, Stippler M, Shi S, et al. Factors predicting reoperation of chronic subdural hematoma following primary surgical evacuation[J]. J Neurosurg, 2018, 129(5): 1143-1150.
|
[32] |
Fornebo I, Sjåvik K, Alibeck M, et al. Role of antithrombotic therapy in the risk of hematoma recurrence and thromboembolism after chronic subdural hematoma evacuation: a population-based consecutive cohort study[J]. Acta Neurochir (Wien), 2017, 159(11): 2045-2052.
|
[33] |
Gaist D, García Rodríguez LA, Hellfritzsch M, et al. Association of antithrombotic drug use with subdural hematoma risk[J]. JAMA, 2017, 317(8): 836-846.
|